Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects

Table 1

Age, gender, Ocular Surface Disease Index (OSDI) score, best-corrected visual acuity (BCVA) in control subjects and in patients with monoclonal gammopathy (MGUS).

—	Age (years) (mean ± SD (minimum-maximum))	Males (n (%))	OSDI (mean ± SD (minimum-maximum))	BCVA (mean ± SD (minimum-maximum))
Control	62.44 ± 11.89 (37–86)	14 (32.56%)	12.66 ± 11.00 (0–50)	0.94 ± 0.16 (0.06–1)
MGUS	67.61 ± 10.48 (38–85)	31 (38.75%)	21.51 ± 18.03 (0–65.9)	0.82 ± 0.26 (0.01–1)
value	0.17	0.67	0.02	0.0005

values refer to results of Mann–Whitney U-test (age, OSDI, and BCVA) and of χ² test with Yates correction (males) (comparison between both groups). Significant values are in bold.